|
lncRNA/circRNA | Deregulation | Detection method | Sample type and the number of samples | Survival analysis and the number of patients enrolled | Survival outcomes correlated with the expression | Clinical characteristics associated with the expression | Biomarker category | Reference |
|
DUXAP8 | ↑ | RT-qPCR | LC tissues; 66 | OS; 66 | Poor survival outcome | TNM stage, LNM | Diagnosis/prognosis | [22] |
IGFBP4-1 | ↑ | RT-qPCR | LC tissues; 159 | — | — | TNM stage | Diagnosis | [23] |
BCYRN1 | ↑ | RT-qPCR | LC tissues; 20 | — | — | — | Diagnosis | [25] |
CRYBG3 | ↑ | RT-qPCR | LC tissues; 23 | — | — | Distant metastasis | Diagnosis | [28] |
LINC00243 | ↑ | RT-qPCR | LC tissues; 59 from TCGA database and 70 from the patients enrolled | OS; 70 | Poor survival outcome | — | Diagnosis/prognosis | [34] |
AC020978 | ↑ | FISH, RT-qPCR | LC tissues; 92(FISH), 16(RT-qPCR) | OS; 92 | Poor survival outcome | TNM stage, LNM, tumor size | Diagnosis/prognosis | [26] |
LINC01123 | ↑ | RNA-seq, FISH, RT-qPCR | NSCLC tissues; 3 (RNA-seq), 92 (FISH), and 16 (RT-qPCR) | OS; 92 | Poor survival outcome | TNM stage, T stage, LNM | Diagnosis/prognosis | [31] |
HOXA11-AS | ↑ | RT-qPCR | LC tissues; 40 | OS; 40 | Poor survival outcome | TNM stage, tumor size, LNM | Diagnosis/prognosis | [33] |
ABHD11-AS1 | ↑ | RT-qPCR | LC tissues; 40 | OS; exact number not mentioned | Poor survival outcome | TNM stage | Diagnosis/prognosis | [35] |
AL355338 | ↑ | FISH, RT-qPCR | LC tissues; 80 (RT-qPCR) | OS; 80 | Poor survival outcome | TNM stage, T stage, LNM, distant metastasis | Diagnosis/prognosis | [36] |
HOTAIRM1 | ↑ | RT-qPCR | NSCLC tissues (exact number not mentioned) | — | — | — | Diagnosis | [37] |
LINC01537 | ↓ | RNA-seq | LC tissues; 8 | Prognostic score in the TCGA LC cohort | Better survival outcome | — | Prognosis | [38] |
ARHGAP10 | ↑ | FISH | LC tissues; 92 | OS; exact number not mentioned | Poor survival outcome | — | Prognosis | [19] |
circMYLK | ↑ | RT-qPCR | LC tissues; 103 | OS; 103 | Poor survival outcome | TNM stage, tumor size | Diagnosis/prognosis | [20] |
circ_0008928 | ↑ | RT-qPCR | Serum exosomes; 28 from cisplatin-sensitive NSCLC patients and 19 from cisplatin-resistant NSCLC patients | — | — | — | Diagnosis | [21] |
circMAGI3 | ↑ | RT-qPCR | LC tissues; 30 | OS; exact number not mentioned | Poor survival outcome | TNM stage | Diagnosis/prognosis | [24] |
circAGFG1 | ↑ | RT-qPCR | NSCLC tissues and corresponding serum samples; 45 | OS; 45 | Poor survival outcome | — | Diagnosis/prognosis | [29] |
circSLC25A16 | ↑ | RT-qPCR | NSCLC tissues; 40 | OS; exact number not mentioned | Poor survival outcome | TNM stage | Diagnosis/prognosis | [30] |
circ-MEMO1 | ↑ | RT-qPCR | NSCLC tissues; 52 | OS; 52 | Poor survival outcome | Clinical stage, LNM | Diagnosis/prognosis | [32] |
circDCUN1D4 | ↓ | ISH | NSCLC tissues; 92 | OS; exact number not mentioned | Better survival outcome | TNM stage | Diagnosis/prognosis | [39] |
circ-ERBB2 | ↑ | RT-qPCR | LC tissues; 31 | — | — | — | Diagnosis | [40] |
circTADA2A | ↑ | RT-qPCR | LC tissues; 30 | — | — | — | Diagnosis | [41] |
circ-PGC | ↑ | RT-qPCR | NSCLC tissues; 33 | OS; exact number not mentioned | Poor survival outcome | TNM stage, tumor size, LNM | Diagnosis/prognosis | [42] |
circPUM1 | ↑ | RT-qPCR | NSCLC tissues; 62 | OS; 62 | Poor survival outcome | TNM stage | Diagnosis/prognosis | [43] |
circ_0000517 | ↑ | RT-qPCR | NSCLC tissues; 60 | OS; 60 | Poor survival outcome | TNM stage, LNM | Diagnosis/prognosis | [44] |
circ-PITX1 | ↑ | RT-qPCR | NSCLC tissues; 41 | — | — | — | Diagnosis | [45] |
circ_0006677 | ↓ | RT-qPCR | NSCLC tissues; 88 | OS; 88 | Better survival outcome | TNM stage, tumor size, LNM | Diagnosis/prognosis | [46] |
circNFIX | ↑ | RT-qPCR | NSCLC tissues; 55 | OS; 55 | Poor survival outcome | TNM stage, distant metastasis | Diagnosis/prognosis | [47] |
circ-ENO1 | ↑ | RT-qPCR | LC tissues; 64 | — | — | — | Diagnosis | [48] |
CTD-2245E15.3 | ↑ | RT-qPCR | NSCLC tissues from TCGA database; 535 | — | — | — | Diagnosis | [49] |
CCAT1 | ↑ | ISH, RT-qPCR | LC tissues; 10 | OS/DFS, 504 | Poor survival outcome | Clinical stage | Diagnosis/prognosis | [50] |
circ-LDLRAD3 | ↑ | RT-qPCR | NSCLC tissues; 60 | — | — | TNM stage; LNM | Diagnosis | [52] |
MINCR | ↑ | RT-qPCR | NSCLC tissues; 35 | OS; exact number not mentioned | Poor survival outcome | — | Diagnosis/prognosis | [53] |
lncRNA-PVT1-5 | ↑ | RT-qPCR | LC tissues; 80 | — | — | — | Diagnosis | [51] |
circ_0003028 | ↑ | RT-qPCR | NSCLC tissues; 53 | — | — | — | Diagnosis | [55] |
|